[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)
Clinical trial NCT01385033 · TERMINATED
Trial details
- NCT number
- NCT01385033
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-19
- Primary completion
- 2012-05-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.